Psoralea corylifolia L.: a comprehensive review of its botany, traditional uses, phytochemistry, pharmacology, toxicology, quality control and pharmacokinetics

Author:

Chen Lele,Chen Shuguang,Sun Peng,Liu Xinyue,Zhan Zhaoshuang,Wang Jiafeng

Abstract

AbstractPsoralea corylifolia L. (PCL), referred to as “Bu-gu-zhi” in Chinese, has great medicinal values since ancient times. PCL is the dried ripe fruit of Psoralea corylifolia L., which has been widely used in traditional Chinese medicine (TCM) for the treatment of kidney-yang deficiency, enuresis and urinary frequency, chills and pain of the waist and knees, dawn diarrhea and vitiligo. In this paper, a systematic of the botany, traditional uses, phytochemistry, pharmacology, toxicology, quality control and pharmacokinetics of PCL was presented, along with future research directions. According to the results, PCL contains approximately 163 chemical components, including coumarins, flavonoids, monoterpene phenols, benzofurans, glycosides, lipids, fatty acids, and volatile oils. PCL and its active ingredients have a variety of pharmacological activities, such as anti-inflammatory, antibacterial, antiviral, antioxidant, antitumor, antiosteoporosis, cardioprotective, neuroprotective, and immunomodulatory. Further study of quality control standards and potential mechanisms of PCL is also needed. In addition, more toxicological studies will also contribute to the progress of clinical trials.

Funder

Qilu School of Traditional Chinese Medicine Academic School Inheritance Project

Shandong Province Graduate Education Quality courses and professional degree graduate teaching case base project

Qingchuang Talents Induction Program of Shandong Higher Education Institution

Publisher

Springer Science and Business Media LLC

Subject

Complementary and alternative medicine,Pharmacology

Reference185 articles.

1. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China. Beijing: China Medical Science Publisher; 2020. p. 195.

2. Flora of China Editorial Committee. Flora of the People’s Republic of China, Part 41. Beijing: Science Press; 1995. p. 344.

3. Zheng Y, Zheng Y. Clinical observation and analysis of Bubai granules in the treatment of leukopenia after tumor radiotherapy and chemotherapy. Guide China Med. 2015;13:188. https://doi.org/10.15912/j.cnki.gocm.2015.34.156.

4. Wang X, Chen BL. Influence of combined application of Buguzhi decoction and femoral head necrosis therapeutic apparatus on hemorheology, hip joint function and bone mineral density of patients with osteonecrosis of femoral head. Clin Res Pract. 2018;3:128–9+140. https://doi.org/10.19347/j.cnki.2096-1413.201822059.

5. Zhang WH, Lai ZF. Fructus psoraleae decoction combined with aricept for 30 vascular dementia patients with deficiency of kidney-essence. J Jiangxi Univ Chin Med. 2017;29(02):36–8.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3